| 7/2/2015 | BKCVDDEMHY | Prospect News reports three new defaults for week of June 25-July 1
|
| 6/25/2015 | CV | Market Commentary: New Impax expands on hedge; NorthStar on deck; Gogo, Penn Virginia up outright; Molycorp lower
|
| 6/25/2015 | BKCVDDHY | Molycorp bankruptcy court filings detail restructuring, funding terms
|
| 6/25/2015 | CV | Market Commentary: New Impax Labs ‘doing fine;’ NorthStar on deck; Molycorp in focus after Chapter 11 filing
|
| 6/25/2015 | BKCVDDHY | Molycorp files for Chapter 11 under $1.7 billion restructuring plan
|
| 6/5/2015 | BKCVDDEMHY | Prospect News reports two new defaults for week of May 28 to June 3
|
| 6/2/2015 | BKCVDDHY | S&P drops Molycorp to D
|
| 6/1/2015 | CV | Market Commentary: FireEye deals add in active trade; Intel better bid on M&A news; SINA up about 0.75 point
|
| 6/1/2015 | BKCVDDHY | Moody’s lowers Molycorp, debt
|
| 6/1/2015 | CVDDHY | Molycorp misses coupon on 10% senior notes, has 30-day grace period
|
| 5/7/2015 | BKCVDDEMIGPV | Market Commentary: Range Resources, Boyd sell; earnings push around commodity names; funds lose $2.75 billion
|
| 5/7/2015 | BKCVDDHY | Molycorp to convert significant portion of outstanding debt for equity
|
| 3/17/2015 | CV | Market Commentary: MGM jumps amid spinoff chatter; energy names hit again by lower oil; Molycorp slumps
|
| 3/17/2015 | BKBWCVDDHY | Molycorp faces ‘substantial debt,’ says going-concern status in doubt
|
| 2/3/2015 | CV | Market Commentary: Isis adds on hedge after drug data disappoints; LinkedIn adds outright, on hedge
|
| 1/26/2015 | CV | Market Commentary: FXCM strengthens; Molycorp adds; Array up; convertibles mostly quiet ahead of Nor’easter
|
| 12/24/2014 | BKCVDDEMHY | S&P global corporate junk default rate declines to 1.56% in November
|
| 12/10/2014 | CVDDHY | S&P upgrades Molycorp
|
| 11/26/2014 | CVDDHY | S&P downgrades Molycorp
|
| 11/21/2014 | CVLM | Molycorp holder to exchange $38 million of 6%, 5.5% convertibles
|
| 11/6/2014 | BKCVDDEMIGPV | Market Commentary: Omnicare, Abengoa price; Avis, Truven drive by; new DISH busy; funds jump $2.44 billion
|
| 11/6/2014 | CV | Market Commentary: LinkedIn gains after pricing at cheap end; Aegerion regains ground; Salix shares plunge
|
| 11/6/2014 | CV | Market Commentary: Morning Commentary: New LinkedIn gains after pricing at the cheap end; Molycorp looks lower
|
| 9/25/2014 | CV | Market Commentary: Convertibles hit as high-yield, equities sell off; new SolarCity drops out of the gate
|
| 9/25/2014 | CV | Market Commentary: Morning Commentary: New SolarCity drops outright, dollar neutral; Molycorp 6% stabilizes
|
| 9/11/2014 | CVLM | Molycorp to repay $27.5 million of convertibles via new term loan
|
| 9/5/2014 | CVDDHY | S&P reviews Molycorp for upgrade
|
| 8/20/2014 | CV | Market Commentary: Convertibles see better buyers; Jazz Pharmaceuticals outperforms; Royal Gold holds gains
|
| 8/20/2014 | CV | Market Commentary: Morning Commentary: Pockets of market see better buyers; Molycorp mixed in active trade
|
| 8/7/2014 | CV | Market Commentary: Synchronoss’ 0.75% notes dominate, trade above par; Empire State prices; MolyCorp mixed
|
| 8/7/2014 | CV | Market Commentary: Morning Commentary: Synchronoss’ new 0.75% notes dominate, trade above par; MolyCorp gains
|
| 7/16/2014 | CVDDHY | S&P downgrades Molycorp
|
| 6/19/2014 | CVHY | Moody’s lowers Molycorp
|
| 5/9/2014 | CV | Market Commentary: Midday Commentary: New Iridium preferreds add on swap with common higher; Molycorp slide continues
|
| 5/9/2014 | CV | Market Commentary: New Iridium preferreds gain on swap with higher common; Citrix better; Molycorp slides
|
| 5/8/2014 | CV | Market Commentary: Cobalt gains on debut; existing Cobalt slips; Molycorp slides after earnings; Insulet adds
|
| 3/4/2014 | BKCVHY | Molycorp ends 2013 with cash, equivalents of $34 million; steps back from securing revolver
|
| 1/23/2014 | CV | Market Commentary: New Colony mostly flat, old Colony 'comes in'; Emergent looks 'fine'; China names in focus
|
| 11/8/2013 | CV | Market Commentary: Midday Commentary: Incyte's two-tranche deal prices, trades up; MolyCorp falls on earnings
|
| 11/8/2013 | CV | Market Commentary: Incyte's $700 million two-tranche deal prices, trades up; Molycorp falls on wider loss
|
| 10/16/2013 | CV | Market Commentary: SolarCity surges in debut; new Resource Capital slips; MolyCorp, American Realty steady
|
| 10/15/2013 | CV | Market Commentary: Midday Commentary: Planned Resource Capital looks cheap; Savient files Chapter 11
|
| 10/15/2013 | CV | Market Commentary: Savient collapses after bankruptcy filing; MolyCorp drops; Resource, SolarCity on tap
|
| 10/4/2013 | CV | Market Commentary: New Campus Crest adds on debut, but shares dive at close; AMR moving up; Tower Group firm
|
| 10/2/2013 | CV | Market Commentary: Short-dated, credit names well bid; Tower bounces after reinsurer deals; Molycorp gains
|
| 8/9/2013 | CV | Market Commentary: Web.com prices deal; YRC falls as Credit Suisse hired; Dendreon declines; MolyCorp drops
|
| 7/10/2013 | CV | Market Commentary: Tesla steady at highs; Allscripts expands on hedge; Vantage Drilling, Merrimack on tap
|
| 6/4/2013 | CV | Market Commentary: New Dominions trade around reoffered price and lower; planned Array note valuations eyed
|
| 3/19/2013 | CV | Market Commentary: Walter gets whacked on earnings miss; Electronic Arts flat to lower on hedge; Navistar up
|
| 2/28/2013 | CV | Market Commentary: BroadSoft expands on hedge as shares plunge; Molycorp lower; MGIC gains; Redwood upsizes
|
| 1/25/2013 | CV | New Issue: Molycorp prices upsized $150 million five-year convertibles to yield 5.5%, up 20%
|
| 1/25/2013 | CV | Market Commentary: Market sees $1 billion in four deals; Auxilium adds on hedge; Molycorp surges with shares
|
| 1/24/2013 | CV | Market Commentary: New KB Home trades flat on hedge on debut; Auxilium offering upsized, talked terms revised
|
| 1/24/2013 | CACVDDHY | S&P rates Molycorp convertibles CCC
|
| 1/23/2013 | CV | MolyCorp plans $100 million five-year convertibles to yield 5.75%-6.25%, up 15%-20%
|
| 1/23/2013 | CV | Market Commentary: Planned KB Home adds in gray; newer Theravance still weak; Molycorp, OPKO, Auxilium on tap
|
| 1/10/2013 | CV | Market Commentary: ArcelorMittal up outright, slips on swap; Silver Standard seen cheap; Molycorp bid lower
|
| 12/14/2012 | CV | Market Commentary: Convertibles generally quiet; Cobalt adds 0.125 point dollar neutral; Micron paper better
|
| 12/10/2012 | CV | Market Commentary: Bottomline extends gains; Dendreon adds about a point; A123 surges on auction; Molycorp up
|
| 11/15/2012 | CV | Market Commentary: AK Steel drops in active trade on debut; Vector adds; NetApp 'comes in' after earnings
|
| 11/8/2012 | CV | Market Commentary: New iStar rises, then fades with stock after deal upsizing; Molycorp slips with shares
|
| 8/31/2012 | CV | Market Commentary: Convertibles mostly flat for week; some see mixed performance for month, but indices gain
|
| 8/30/2012 | CV | Market Commentary: Trading thins; James River jumps; Ciena in focus after disappointing quarter; Molycorp up
|
| 8/29/2012 | CV | MolyCorp greenshoe exercise lifts 6% convertibles deal to $414 million
|
| 8/29/2012 | CV | Market Commentary: Molycorp extends hedged gain on Mountain Pass news; ADM weak; Alpha Natural 'in' some
|
| 8/28/2012 | CV | Market Commentary: Molycorp expands on hedge as rare earths project advances; SanDisk, Electronic Arts gain
|
| 8/22/2012 | CACVDDHY | S&P rates Molycorp convertibles CCC+
|
| 8/21/2012 | CV | Market Commentary: MolyCorp trades weakly on second day in the market; Medtronic active ahead of earnings
|
| 8/20/2012 | CV | Market Commentary: MolyCorp trades weakly on second day in the market; Medtronic active ahead of earnings
|
| 8/17/2012 | CV | New Issue: MolyCorp prices upsized $360 million five-year convertible notes at 6%, up 20%
|
| 8/17/2012 | CV | Market Commentary: Investors keen on MolyCorp's new issue; Suntech paper sinks on CEO exit; AuRico sparkles
|
| 8/17/2012 | CVDDHY | Moody's downgrades Molycorp
|
| 8/16/2012 | CVHYPF | Molycorp files automatic shelf covering debt, preferreds and stock
|
| 8/16/2012 | CV | MolyCorp to issue $300 million five-year convertible senior notes
|
| 8/16/2012 | CV | Market Commentary: MolyCorp plans to sell $300 million convertibles; EA, Coinstar paper boosted on sale talk
|
| 8/13/2012 | CVDDHY | S&P cuts Molycorp
|
| 8/3/2012 | CV | Market Commentary: Knight Capital bounces on potential buyout; Molycorp plunges on warning; MGIC stumbles
|
| 7/5/2012 | CVHY | S&P rates Molycorp notes B
|
| 5/15/2012 | CV | Market Commentary: Patriot Coal drops, postpones credit facility; Chesapeake slips further; Molycorp quiet
|
| 5/14/2012 | CVHY | S&P rates Molycorp notes B
|
| 5/14/2012 | CVHY | Moody's rates Molycorp notes B2
|
| 3/9/2012 | CV | Market Commentary: Ares puts in lackluster debut; Priceline comes 'in' slightly; Molycorp deal pushes stock
|
| 12/30/2011 | CV | Outlook 2012: MF Global's two convertibles deals: A 'black eye' for the market
|
| 8/3/2011 | CV | Market Commentary: Convertibles find footing; high-grade names outperform junk; Mylan drops; Cemex weaker
|
| 6/21/2011 | CV | Market Commentary: Molycorp, Brookdale up; Boston Properties adds outright, slips on hedge; NuVasive on tap
|
| 6/16/2011 | CV | Molycorp greenshoe exercised, lifting convertibles to $230 million
|
| 6/10/2011 | CV | New Issue: Molycorp prices $200 million five-year convertibles at 3.25%, up 40%
|
| 6/10/2011 | CV | Market Commentary: Molycorp jumps on debut, but Integra drops; new Brookside extends losses; Vertex expands
|
| 6/9/2011 | CV | Molycorp revises price talk on $200 million five-year convertibles to 3%-3.5%, up 37.5%-40%
|
| 6/9/2011 | CV | Market Commentary: Brookdale slips on debut; Forestar scraps deal; Molycorp looks cheap after revised talk
|
| 6/8/2011 | CV | Market Commentary: Suntech Power gaps lower; Hanwha SolarOne trades; Ciena steady on hedge after earnings
|
| 6/7/2011 | CV | Market Commentary: Contagion hits China Medical; Forestar looks a little cheap; Molycorp, Brookdale launch
|
| 6/7/2011 | CV | Molycorp to price $200 million five-year convertibles to yield 3.25%-3.75%, up 27.5%-32.5%
|
| 5/11/2011 | CV | Market Commentary: PDL BioPharma up outright, flat on swap on debut; Rovi adds dollar neutral as stock surges
|
| 2/11/2011 | CV | New Issue: Molycorp details emerge in upsized $180 million three-year mandatory convertibles
|
| 2/11/2011 | CV | Market Commentary: Molycorp drops; called Ford preferreds 'come in' a couple of points; Wright Medical jumps
|
| 2/10/2011 | CV | Market Commentary: Charles River adds slightly on hedge; Energy Conversion higher; Molycorp upsizes, prices
|
| 2/10/2011 | CV | New Issue: Molycorp sells upsized $180 million three-year mandatory convertibles at 5.5%, up 20%
|
| 2/7/2011 | CV | Molycorp's $150 million three-year mandatory convertibles talked at 5.75%-6.25%, up 17.5%-22.5%
|
| 2/7/2011 | CV | Market Commentary: Beckman 'comes in' on hedge; Chesapeake up on planned asset sale talk; MF Global on tap
|
| 1/31/2011 | CV | Market Commentary: Massey Energy up on merger; Alpha Natural off; Savient upsizes; Avatar, Hovnanian on tap
|
| 1/24/2011 | CV | Molycorp plans $172.5 million mandatory convertible preferreds, $500 million secondary offering
|
| 1/24/2011 | CV | Market Commentary: Salesforce.com under pressure; RadioShack lower; Molycorp plans mandatory; Nielsen on tap
|
